1 October 2025 -- Missouri, US -- Likarda, a global leader in complex therapy formulation for cell and large-molecule therapeutics, today announced the launch of Predictive Polymer Analytics (PPA), its next-generation artificial intelligence (AI) platform designed to radically accelerate and de-risk the formulation design process for clients developing advanced therapeutics.

1 October 2025 -- California, US and Seoul, South Korea -- Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostics products, and Gencurix, Inc, a leading Korean developer of oncology testing solutions, today announced the signing of a strategic agreement establishing Bio-Rad as the exclusive distributor of Gencurix’ CE-IVD Droplex™ digital PCR oncology testing kits throughout Europe.

natoli.com/fastlok

www.flypharmaeurope.com

IPT Autumn 2025 events page

How is the industry translating the potential of automated technologies into practical, flexible and scalable workflows that address the real-world challenges of modern laboratories, ensuring that innovation delivers measurable scientific and operational gains?

How is artificial intelligence, when delivered through software as a service platforms, unlocking real business outcomes for pharmaceutical manufacturers, from faster batch release and smarter investigations to smoother tech transfers and enterprise-wide compliance?

How is artificial intelligence changing the way drug discovery and development is enacted across the sector, yielding not only impressive potential, but also clinically validated pharma products?

https://posummit.com/

Artificial intelligence-powered de novo protein design is opening new pathways in biologics discovery, allowing researchers to create synthetic proteins beyond nature’s existing repertoire

What is single-stranded DNA and why is it a viable viral vector alternative?

How will innovative human-centred in vitro testing strategies contribute to accelerating the delivery of safer and more effective therapies to patients without, or with minimal, use of animal models?